Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Singh: Thiazolidinediones and heart failure. (0.12 sec) 

Thiazolidinediones and heart failure

- diabetesjournals.org
S Singh, YK Loke, CD Furberg - Diabetes Care, 2007 - Am Diabetes Assoc
RESULTS—A random-effects meta-analysis of three randomized controlled trials
showed an odds ratio (OR) of 2.1 (95% CI 1.08–4.08; P = 0.03) for the risk of
heart failure in patients randomized to TZDs compared with placebo. Four ...
Cited by 64 - Related articles - BL Direct - All 10 versions

Thiazolidinediones and Heart Failure: A Teleo-Analysis Received for publication 23 …


S Singh, YKL MBBS, CDFMD PhD, S Singh - Am Diabetes Assoc
Received for publication 23 January 2007 and accepted in revised form 18 May
2007. ... Sonal Singh MD 1 * Yoon K Loke MBBS MD 2* Curt D Furberg MD PhD 3
... 1 Internal Medicine, Wake Forest University School of Medicine, NC 2 ...
Related articles

Thiazolidinediones and the risk of edema: a meta-analysis


HD Berlie, JS Kalus, LA Jaber - Diabetes research and clinical practice, 2007 - Elsevier
The use of thiazolidinediones (TZDs) in the management of type 2 diabetes
mellitus (T2DM) has been associated with an increased risk of peripheral edema.
A meta-analysis was performed to assess the overall risk for developing ...
Cited by 34 - Related articles - All 10 versions

Rosiglitazone for type 2 diabetes mellitus.


B Richter, E Bandeira-Echtler, K Bergerhoff, … - Cochrane database of systematic reviews (Online), 2007 - ncbi.nlm.nih.gov
BACKGROUND: Diabetes has long been recognised as a strong, independent risk
factor for cardiovascular disease, a problem which accounts for approximately
70% of all mortality in people with diabetes. Prospective studies show that ...
Cited by 55 - Related articles

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

- infodiabetes.it [PDF] 
S Singh, YK Loke, CD Furberg - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Recent reports of ...
Cited by 304 - Related articles - BL Direct - All 12 versions

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 …


RM Lago, PP Singh, RW Nesto - The Lancet, 2007 - Elsevier
360 of 20 191 patients who had either prediabetes or type 2 diabetes had
congestive heart failure events (214 with TZDs and 146 with comparators).
Results showed no heterogeneity of effects across studies (I 2 =22·8%; p ...
Cited by 180 - Related articles - BL Direct - All 7 versions

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a …


AM Lincoff, K Wolski, SJ Nicholls, SE Nissen - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Pioglitazone is ...
Cited by 325 - Related articles - BL Direct - All 7 versions

Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased …

- oxfordjournals.org
E Erdmann, RG Wilcox - European Heart Journal, 2008 - Eur Soc Cardiology
Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2008. For permissions please email:
journals.permissions@oxfordjournals.org The online version of this article ...
Cited by 33 - Related articles - BL Direct - All 7 versions

Use of thiazolidinediones and fracture risk

- ammom.com.mx [PDF] 
C Meier, ME Kraenzlin, M Bodmer, SS Jick, H … - Archives of Internal Medicine, 2008 - Am Med Assoc
Methods This study examines the association between the use of
thiazolidinediones or other oral antidiabetic drugs and the risk of fracture.
This nested case-control analysis uses the UK General Practice Research ...
Cited by 70 - Related articles - BL Direct - All 8 versions

Effect of various diuretic treatments on rosiglitazone-induced fluid retention

- asnjournals.org
J Karalliedde, R Buckingham, M Starkie, D … - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
The efficacy of diuretics in the management of rosiglitazone (RSG)-induced fluid
retention was evaluated in a multicenter, randomized, open-label,
parallel-group, proof-of-concept study. Of 381 patients who had type 2 ...
Cited by 39 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google